Regenerative medicine in kidney disease: where we stand and where to go

Review

Abstract

The kidney is a complex organ with more than 20 types of specialized cells that play an important role in maintaining the body’s homeostasis. The epithelial tubular cell is formed during embryonic development and has little proliferative capacity under physiological conditions, but after acute injury the kidney does have regenerative capacity. However, after repetitive or severe lesions, it may undergo a maladaptation process that predisposes it to chronic kidney injury. Regenerative medicine includes various repair and regeneration techniques, and these have gained increasing attention in the scientific literature. In the future, not only will these techniques contribute to the repair and regeneration of the human kidney, but probably also to the construction of an entire organ. New mechanisms studied for kidney regeneration and repair include circulating stem cells as mesenchymal stromal/stem cells and their paracrine mechanisms of action; renal progenitor stem cells; the leading role of tubular epithelial cells in the tubular repair process; the study of zebrafish larvae to understand the process of nephron development, kidney scaffold and its repopulation; and, finally, the development of organoids. This review elucidates where we are in terms of current scientific knowledge regarding these mechanisms and the promises of future scientific perspectives.

Keywords

Kidney disease Regenerative medicine Stem cells Zebrafish Organoids Bioengineering 

References

  1. 1.
    Sugai K, Fukuzawa R, Shofuda T, Fukusumi H, Kawabata S, Nishiyama Y, Higuchi Y, Kawai K, Isoda M, Kanematsu D, Hashimoto-Tamaoki T, Kohyama J, Iwanami A, Suemizu H, Ikeda E, Matsumoto M, Kanemura Y, Nakamura M, Okano H (2016) Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases. Mol Brain 9:85CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Fong C-Y, Gauthaman K, Bongso A (2010) Teratomas from pluripotent stem cells: a clinical hurdle. J Cell Biochem 111:769–781CrossRefPubMedGoogle Scholar
  3. 3.
    Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–1301CrossRefPubMedGoogle Scholar
  4. 4.
    Ren H, Sang Y, Zhang F, Liu Z, Qi N, Chen Y (2016) Comparative analysis of human mesenchymal stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy. Stem Cells Int 2016:3516574CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Squillaro T, Peluso G, Galderisi U (2016) Clinical trials with mesenchymal stem cells: an update. Cell Transplant 25:829–848CrossRefPubMedGoogle Scholar
  6. 6.
    Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317CrossRefPubMedGoogle Scholar
  7. 7.
    Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A (2005) Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7:393–395CrossRefPubMedGoogle Scholar
  8. 8.
    Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272:60–66CrossRefPubMedGoogle Scholar
  9. 9.
    Segers VF, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJ, Kockx MM, De Keulenaer GW (2006) Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol 290:H1370–H1377CrossRefPubMedGoogle Scholar
  10. 10.
    Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N (2012) Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One 7:e44092CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Caldas HC, de Paula Couto TA, Fernandes IM, Baptista MA, Kawasaki-Oyama RS, Goloni-Bertollo EM, Braile DM, Abbud-Filho M (2015) Comparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failure. Clin Exp Nephrol 19:783–789CrossRefPubMedGoogle Scholar
  12. 12.
    Oliveira-Sales EB, Maquigussa E, Semedo P, Pereira LG, Ferreira VM, Câmara NO, Bergamaschi CT, Campos RR, Boim MA (2013) Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture. PLoS One 8:e78464CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Zhuo W, Liao L, Xu T, Wu W, Yang S, Tan J (2011) Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney. Urol Int 86:191–196CrossRefPubMedGoogle Scholar
  14. 14.
    Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, Selig M, Godwin J, Law K, Placidi C, Smith RN, Capella C, Rodig S, Adra CN, Atkinson M, Sayegh MH, Abdi R (2009) Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183:993–1004CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Wise AF, Williams TM, Kiewiet MB, Payne NL, Siatskas C, Samuel CS, Ricardo SD (2014) Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. Am J Physiol Ren Physiol 306:F1222–F1235CrossRefGoogle Scholar
  16. 16.
    Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, Kuo HP, Chong KY (2015) Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis. Stem Cell Res Ther 6:97CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135:799–808CrossRefPubMedGoogle Scholar
  18. 18.
    Liu J, Zhu P, Song P, Xiong W, Chen H, Peng W, Wang S, Li S, Fu Z, Wang Y, Wang H (2015) Pretreatment of adipose derived stem cells with Curcumin facilitates myocardial recovery via antiapoptosis and angiogenesis. Stem Cells Int 2015:638153PubMedPubMedCentralGoogle Scholar
  19. 19.
    Li N, Yang YJ, Qian HY, Li Q, Zhang Q, Li XD, Dong QT, Xu H, Song L, Zhang H (2015) Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4. Am J Transl Res 7:1058–1070PubMedPubMedCentralGoogle Scholar
  20. 20.
    Lu H, Wu X, Wang Z, Li L, Chen W, Yang M, Huo D, Zeng W, Zhu C (2016) Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment. J Surg Res 205:464–473CrossRefPubMedGoogle Scholar
  21. 21.
    Yu J, Liu XL, Cheng QG, Lu SS, Xu XQ, Zu QQ, Liu S (2016) G-CSF and hypoxic conditioning improve the proliferation, neural differentiation and migration of canine bone marrow mesenchymal stem cells. Exp Ther Med 12:1822–1828PubMedPubMedCentralGoogle Scholar
  22. 22.
    Dakhlallah D, Zhang J, Yu L, Marsh CB, Angelos MG, Khan M (2015) MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J Cardiovasc Pharmacol 65:241–251CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Dekel B, Shezen E, Even-Tov-Friedman S, Katchman H, Margalit R, Nagler A, Reisner Y (2006) Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells 24:1185–1193CrossRefPubMedGoogle Scholar
  24. 24.
    Dziedzic K, Pleniceanu O, Dekel B (2014) Kidney stem cells in development, regeneration and cancer. Semin Cell Dev Biol 36:57–65CrossRefPubMedGoogle Scholar
  25. 25.
    Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, Tetta C, Camussi G (2012) Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7:e33115CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38:215–224CrossRefPubMedGoogle Scholar
  27. 27.
    Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M (2006) In vivo genetic selection of renal proximal tubules. Mol Ther 13:49–58CrossRefPubMedGoogle Scholar
  28. 28.
    Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW (2002) Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416:542–545CrossRefPubMedGoogle Scholar
  29. 29.
    Nigam eS, Lieberthal W (2000) Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Ren Physiol 279:F3–F11Google Scholar
  30. 30.
    Razban V, Lotfi AS, Soleimani M, Ahmadi H, Massumi M, Khajeh S, Ghaedi M, Arjmand S, Najavand S, Khoshdel A (2012) HIF-1α Overexpression induces angiogenesis in Mesenchymal stem cells. Biores Open Access 1:174–183CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Xing L, Cui R, Peng L, Ma J, Chen X, Xie RJ, Li B (2014) Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury. Stem Cell Res Ther 5:101CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Dai C, Liu Y (2004) Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 15:1402–1412CrossRefPubMedGoogle Scholar
  33. 33.
    Mizuno S, Matsumoto K, Kurosawa T, Mizuno-Horikawa Y, Nakamura T (2000) Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 57:937–948CrossRefPubMedGoogle Scholar
  34. 34.
    Borges FT, Reis LA, Schor N (2013) Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res 46:824–830CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053–1067CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Zou X, Zhang G, Cheng Z, Yin D, Du T, Ju G, Miao S, Liu G, Lu M, Zhu Y (2014) Microvesicles derived from human Wharton’s jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1. Stem Cell Res Ther 5:40CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Nassar W, El-Ansary M, Sabry D, Mostafa MA, Fayad T, Kotb E, Temraz M, Saad AN, Essa W, Adel H (2016) Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 20:21CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Bouffi C, Bony C, Courties G, Jorgensen C, Noël D (2010) IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 5:e14247CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Bartosh TJ, Ylöstalo JH, Bazhanov N, Kuhlman J, Prockop DJ (2013) Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1). Stem Cells 31:2443–2456CrossRefPubMedGoogle Scholar
  40. 40.
    Bartosh TJ, Ylöstalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ (2010) Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their anti-inflammatory properties. Proc Natl Acad Sci USA 107:13724–13729CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Dressler GR (2006) The cellular basis of kidney development. Annu Rev Cell Dev Biol 22:509–529CrossRefPubMedGoogle Scholar
  42. 42.
    Maeshima A, Yamashita S, Nojima Y (2003) Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 14:3138–3146CrossRefPubMedGoogle Scholar
  43. 43.
    Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, Camussi G (2005) Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166:545–555CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Ronconi E, Sagrinati C, Angelotti ML, Lazzeri E, Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci M, Carini M, Maggi E, Serio M, Vannelli GB, Lasagni L, Romagnani S, Romagnani P (2009) Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20:322–332CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Wanner N, Hartleben B, Herbach N, Goedel M, Stickel N, Zeiser R, Walz G, Moeller MJ, Grahammer F, Huber TB (2014) Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 25:707–716CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Angelotti ML, Ronconi E, Ballerini L, Peired A, Mazzinghi B, Sagrinati C, Parente E, Gacci M, Carini M, Rotondi M, Fogo AB, Lazzeri E, Lasagni L, Romagnani P (2012) Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30:1714–1725CrossRefPubMedGoogle Scholar
  47. 47.
    Harari-Steinberg O, Metsuyanim S, Omer D, Gnatek Y, Gershon R, Pri-Chen S, Ozdemir DD, Lerenthal Y, Noiman T, Ben-Hur H, Vaknin Z, Schneider DF, Aronow BJ, Goldstein S, Hohenstein PDB (2013) Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease. EMBO Mol Med 5:1556–1568CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Pode-Shakked N, Pleniceanu O, Gershon R, Shukrun R, Kanter I, Bucris E, Pode-Shakked B, Tam G, Tam H, Caspi R, Pri-Chen S, Vax E, Katz G, Omer D, Harari-Steinberg O, Kalisky T, Dekel B (2016) Dissecting stages of human kidney development and tumorigenesis with surface markers affords simple prospective purification of Nephron stem cells. Sci Rep 6:23562CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    O’Brien LL, McMahon AP (2014) Induction and patterning of the metanephric nephron. Semin Cell Dev Biol 36:31–38CrossRefPubMedGoogle Scholar
  50. 50.
    Rinkevich Y, Montoro DT, Contreras-Trujillo H, Harari-Steinberg O, Newman AM, Tsai JM, Lim X, Van-Amerongen R, Bowman A, Januszyk M, Pleniceanu O, Nusse R, Longaker MT, Weissman IL, Dekel B (2014) In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep 7:1270–1283CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Romagnani P, Rinkevich Y, Dekel B (2015) The use of lineage tracing to study kidney injury and regeneration. Nat Rev Nephrol 11:420–431CrossRefPubMedGoogle Scholar
  52. 52.
    Buzhor E, Harari-Steinberg O, Omer D, Metsuyanim S, Jacob-Hirsch J, Noiman T, Dotan Z, Goldstein RS, Dekel B (2011) Kidney spheroids recapitulate tubular organoids leading to enhanced tubulogenic potency of human kidney-derived cells. Tissue Eng A 17:2305–2319CrossRefGoogle Scholar
  53. 53.
    Buzhor E, Omer D, Harari-Steinberg O, Dotan Z, Vax E, Pri-Chen S, Metsuyanim S, Pleniceanu O, Goldstein RS, Dekel B (2013) Reactivation of NCAM1 defines a subpopulation of human adult kidney epithelial cells with clonogenic and stem/progenitor properties. Am J Pathol 183:1621–1633CrossRefPubMedGoogle Scholar
  54. 54.
    Little MH (2006) Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17:2390–2401CrossRefPubMedGoogle Scholar
  55. 55.
    Kusaba T, Lalli M, Kramann R, Kobayashi A, Humphreys BD (2014) Differentiated kidney epithelial cells repair injured proximal tubule. Proc Natl Acad Sci USA 111:1527–1532CrossRefPubMedGoogle Scholar
  56. 56.
    Berger K, Bangen JM, Hammerich L, Liedtke C, Floege J, Smeets B, Moeller MJ (2014) Origin of regenerating tubular cells after acute kidney injury. Proc Natl Acad Sci USA 111:1533–1538CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Dekel B, Zangi L, Shezen E, Reich-Zeliger S, Eventov-Friedman S, Katchman H, Jacob-Hirsch J, Amariglio N, Rechavi G, Margalit R, Reisner Y (2006) Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 17:3300–3314CrossRefPubMedGoogle Scholar
  58. 58.
    Hu Y, Li M, Göthert JR, Gomez RA, Sequeira-Lopez ML (2016) Hemovascular progenitors in the kidney require sphingosine-1-phosphate receptor 1 for vascular development. J Am Soc Nephrol 27:1984–1995CrossRefPubMedGoogle Scholar
  59. 59.
    Reimschuessel R, Bennett RO, May EB, Lipsky MM (1990) Development of newly formed nephrons in the goldfish kidney following hexachlorobutadiene-induced nephrotoxicity. Toxicol Pathol 18:32–38CrossRefPubMedGoogle Scholar
  60. 60.
    Fine L (1986) The biology of renal hypertrophy. Kidney Int 29:619–634CrossRefPubMedGoogle Scholar
  61. 61.
    Kettleborough RN, Busch-Nentwich EM, Harvey SA, Dooley CM, de Bruijn E, van Eeden F, Sealy I, White RJ, Herd C, Nijman IJ, Fényes F, Mehroke S, Scahill C, Gibbons R, Wali N, Carruthers S, Hall A, Yen J, Cuppen E, Stemple DL (2013) A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 496:494–497CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Drummond IA, Majumdar A, Hentschel H, Elger M, Solnica-Krezel L, Schier AF, Neuhauss SC, Stemple DL, Zwartkruis F, Rangini Z, Driever W, Fishman MC (1998) Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 125:4655–4667PubMedGoogle Scholar
  63. 63.
    Benigni A, Gagliardini E, Tomasoni S, Abbate M, Ruggenenti P, Kalluri R, Remuzzi G (2004) Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 65:2193–2200CrossRefPubMedGoogle Scholar
  64. 64.
    Sun Z, Hopkins N (2001) Vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain. Genes Dev 15:3217–3229CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Froguel P, Velho G (1999) Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 10:142–146CrossRefPubMedGoogle Scholar
  66. 66.
    Cianciolo Cosentino C, Roman BL, Drummond IA, Hukriede NA (2010) Intravenous microinjections of zebrafish larvae to study acute kidney injury. J Vis Exp 42:3–7Google Scholar
  67. 67.
    Diep CQ, Ma D, Deo RC, Holm TM, Naylor RW, Arora N, Wingert RA, Bollig F, Djordjevic G, Lichman B, Zhu H, Ikenaga T, Ono F, Englert C, Cowan CA, Hukriede NA, Handin RI, Davidson AJ (2011) Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature 470:95–100CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Kamei CN, Liu Y, Drummond IA (2015) Kidney regeneration in adult Zebrafish by Gentamicin induced injury. J Vis Exp 102:e51912Google Scholar
  69. 69.
    Nakayama KH, Batchelder CA, Lee CI, Tarantal AF (2010) Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng A 16:2207–2216CrossRefGoogle Scholar
  70. 70.
    Song JJ, Guyette JP, Gilpin SE, Gonzalez G, Vacanti JP, Ott HC (2013) Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 19:646–651CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    O’Neill JD, Freytes DO, Anandappa AJ, Oliver JA, Vunjak-Novakovic GV (2013) The regulation of growth and metabolism of kidney stem cells with regional specificity using extracellular matrix derived from kidney. Biomaterials 34:9830–9841CrossRefPubMedGoogle Scholar
  72. 72.
    Ross EA, Williams MJ, Hamazaki T, Terada N, Clapp WL, Adin C, Ellison GW, Jorgensen M, Batich CD (2009) Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 20:2338–2347CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV (2015) Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol 33:1193–1200CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, Saad AF, Li MK, Hughes MR, Werff RV, Peters DT, Lu J, Baccei A, Siedlecki AM, Valerius MT, Musunuru K, McNagny KM, Steinman T, Zhou J, Lerou PH, Bonventre JV (2015) Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun 6:8715CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Schutgens F, Verhaar MC, Rookmaaker MB (2016) Pluripotent stem cell-derived kidney organoids: an in vivo-like in vitro technology. Eur J Pharmacol 790:12–20CrossRefPubMedGoogle Scholar
  76. 76.
    Takasato M, Er PX, Chiu HS, Little MH (2016) Generation of kidney organoids from human pluripotent stem cells. Nat Protoc 11:1681–1692CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2017

Authors and Affiliations

  1. 1.Nephrology Division, Department of MedicineUniversidade Federal de São Paulo (UNIFESP)São PauloBrazil
  2. 2.Postgraduate Program, Health Sciences–CBSUniversidade Cruzeiro do SulSão PauloBrazil

Personalised recommendations